NCT01149733

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions

A Single-Dose, Comparative Bioavailability Study of Two Formulations of Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 32 (actual)
• Sponsor: Teva Pharmaceuticals USA · Industry
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The objective of this study is to evaluate the comparative bioavailability between tamsulosin hydrochloride 0.4 mg capsules (Manufactured by Teva Pharmaceutical Industries Ltd.; distributed by Teva Pharmaceuticals USA) and Flomax® (tamsulosin hydrochloride)0.4 mg capsules (Manufactured by Yamanouchi Pharmaceutical Co., Japan; distributed by Boehringer Ingelheim Pharmaceutical Inc. USA), after a single-dose in healthy subjects under fed conditions.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Tamsulosin	Test 0.4 mg Capsule
DRUG	Tamsulosin	Reference Listed 0.4 Capsule

Timeline

• Start date: 2004-11-01
• Primary completion: 2004-11-01
• Completion: 2004-11-01
• First posted: 2010-06-23
• Last updated: 2024-08-20
• Results posted: 2010-09-13

Locations

1 site across 1 country: Canada